Dtsch Med Wochenschr 2012; 137(48): 2499
DOI: 10.1055/s-0032-1327302
Pro & Contra | Commentary
Hypertensiologie
© Georg Thieme Verlag KG Stuttgart · New York

Duale RAS-Blockade in der antihypertensiven Therapie – contra

Dual blockade of the renin-angiotensin system in hypertensive treatment: no
M. van der Giet
1   Medizinische Klinik mit SP Nephrologie, Charite – Universitätsmedizin Berlin Campus Benjamin Franklin
› Author Affiliations
Further Information

Publication History

Publication Date:
20 November 2012 (online)

 
  • Literatur

  • 1 Parving HH, Brenner BM, McMurray JJ et al. Cardiorenal end points in a trial of aliskiren for type 2 diabetes. N Engl J Med 2012; DOI: 10.1056/NEJMoa1208799.
  • 2 Yusuf S, Teo KK, Pogue J et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008; 358: 1547-1559